Company Performance Metrics
- Sella Brosh: Founding member, CEO
- Ilai Schwartz: Co-Founder, CTO
NVision is pioneering a new generation of quantum systems designed to bring quantum computing and quantum sensing out of the lab and into the real world, transforming how diseases are understood, detected, and treated.
We engineer and control the quantum properties of organic molecules, integrating molecular design and quantum hardware into
scalable products.
Our POLARIS platform uses quantum-based hyperpolarization to enable real-time metabolic MRI with more than 10,000x signal enhancement, supporting non-invasive, early-stage disease detection and treatment monitoring.
In 2026, we introduced PIQC (Photonic Integrated Quantum Circuits), a fundamentally new quantum computing architecture that combines molecular qubits with photonic integrated circuits to enable scalable biological modeling and next generation drug discovery.
At NVision, we see these technologies converging into a new “compute and validate” paradigm, where quantum systems are used both to design therapies and to measure their biological impact.
